Hepatobiliary dysfunction in Type-2 diabetes mellitus

Hepatobiliary dysfunction in Type-2 diabetes mellitus

Objective: Nonalcoholic fatty liver disease (NAFLD) and gallstones are frequently present in diabetics, but its exact prevalence is not well studied in India. We have done a prevalence study of hepatobiliary involvement in Type-2 diabetes mellitus (T2DM) and also studied the other risk factors of NA...

Full description

Bibliographic Details
Main Authors:	Piyush Manoria, Sameer Inamdar, Ravindra Kumar
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Journal of Family Medicine and Primary Care
Subjects:	Dyslipidemia fatty liver gallstone nonalcoholic fatty liver disease Type-2 diabetes mellitus
Online Access:	http://www.jfmpc.com/article.asp?issn=2249-4863;year=2017;volume=6;issue=3;spage=563;epage=567;aulast=Manoria

Similar Items

Nonalcoholic fatty liver disease and Type 2 diabetes mellitus
by: Mala Dharmalingam, et al.
Published: (2018-01-01)

Diagnostics of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in Combination with Nonalcoholic Fatty Liver Disease (Literature Review and Own Data)
by: N.O. Кravchun, et al.
Published: (2015-08-01)

The Role of Disturbances of Bioelement Metabolism in Nonalcoholic Fatty Liver Disease in Patients with Diabetes Mellitus Type 2
by: L.V. Zhuravlyova, et al.
Published: (2014-09-01)

Effect of Probiotic Therapy on Clinical-Biochemical and Instrumental Parameters of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
by: G.P. Mykhalchyshyn, et al.
Published: (2014-05-01)

Predictors of NAFLD rapidly progression in type 2 diabetes patients
by: G. Mykhalchyshyn
Published: (2020-10-01)

Role of fatty acids in pathogenetic mechanisms of NAFLD progression among type 2 diabetes patients
by: G. Mykhalchyshyn
Published: (2020-11-01)

Evaluation of Liver in Type 2 Diabetes Mellitus Using Unenhanced Computed Tomography
by: Huda Osama, et al.
Published: (2020-12-01)

A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease
by: Sangeetha Suresh, et al.
Published: (2018-01-01)

Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
by: Xiu L, et al.
Published: (2021-07-01)

Prevalence of non- alcoholic fatty liver disease among type-2 diabetes mellitus patients – A cross-sectional hospital based study
by: M.V. Jali, et al.
Published: (2015-01-01)

Correlation of Metabolic Indices with Plasma Leptin Level in Patients with Nonalcoholic Fatty Liver Disease in Combination with Type 2 Diabetes Mellitus and Obesity
by: O.V. Ogneva
Published: (2012-04-01)

Relationship between serum osteocalcin level and glucose and lipid metabolism in patients with type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
by: Ying Shen, et al.
Published: (2019-05-01)

Baseline Values of Nonalcoholic Fatty Liver Disease Scores and Its Risk Assessment in Patients with Type 2 Diabetes Mellitus
by: Kalpesh Joshi, et al.
Published: (2021-08-01)

Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
by: Aasim, M., et al.
Published: (2022)

Nonalcoholic steatohepatitis in posttransplantation liver: Review article
by: Antônio Ricardo Cardia Ferraz de Andrade, et al.

Ipragliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, Ameliorates Nonalcoholic Fatty Liver Disease in Japanese Patients with Type 2 Diabetes Mellitus
by: Kanako Tashima, et al.
Published: (2019-05-01)

Influence of Hyperhomocysteinemia Correction on Functional Liver Tests and Lipid Profile in Patients with Nonalcoholic Fatty Liver Disease in Combination with Type 2 Diabetes Mellitus
by: V.F. Orlovskyi, et al.
Published: (2015-08-01)

Diagnosis of Diabetic Encephalopathy According to Psychometric Tests in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
by: Yu.I. Karatchentsev, et al.
Published: (2014-02-01)

Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus
by: Linxin Xu, et al.
Published: (2019-08-01)

Influence of amorphous nanosilica on the parameters of multiparametric ultrasound investigation in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
by: P.M. Воdnar, et al.
Published: (2017-04-01)

Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes
by: Marta Patita, et al.
Published: (2019-01-01)

L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function
by: Xia Yunqiu, et al.
Published: (2011-11-01)

Influence of nutrient correction on adiponectin circulating level and cardiovascular risk factors in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
by: I.P. Dunayeva
Published: (2017-02-01)

Clinical and Biochemical Predictors of Nonalcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus Patients at Primary Health Care Level in South Western Saudi Arabia
by: Suliman M. Al Humayed, et al.
Published: (2020-10-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Using the principle of multiparametric ultrasound for the diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
by: N.A. Marunchyn, et al.
Published: (2017-03-01)

Safety and Effectiveness of Rosiglitazone in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease
by: Chao-Hung Wang, et al.
Published: (2006-01-01)

The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET/CT study
by: Lijun Hu, et al.
Published: (2018-10-01)

Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet
by: Victoria Svop Jensen, et al.
Published: (2021-02-01)

Therapeutic efficacy of atorvastatin in treatment of non-alcoholic fatty liver disease in patients with type Ⅱ diabetes mellitus
by: FENG Mengdie
Published: (2013-07-01)

Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?
by: Shaheen Tomah, et al.
Published: (2020-06-01)

METABOLIC MARKERS OF CARDIOVASCULAR DISEASE AND TYPE 2 DIABETES MELLITUS IN VARIOUS CLINICAL AND MORPHOLOGICAL FORMS OF NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH ABDOMINAL OBESITY
by: Ksenya Komshilova, et al.
Published: (2018-10-01)

Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes
by: Ningjian Wang, et al.
Published: (2020-01-01)

PLEYOTROPIC EFFECTS OF METFORMIN
by: L. Ju. Morgunov
Published: (2015-01-01)

RECURRENCE OF BREAST CANCER AFTER SUBCUTANEOUS MASTECTOMY WITH SIMULTANEOUS RECONSTRUCTION
by: A. D. Zikiryakhodzhaev, et al.
Published: (2015-01-01)

Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice
by: JuanJuan Sun, et al.
Published: (2020-11-01)

Significance of hepatic fibrosis markers in early diagnosis of type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
by: Lei-Qun Lu, et al.
Published: (2019-07-01)

Bidirectional Association between Nonalcoholic Fatty Liver Disease and Gallstone Disease: A Cohort Study
by: Yoosoo Chang, et al.
Published: (2018-11-01)

Connection Between Non-Alcoholic Fatty Liver Disease and Diabetes Mellitus
by: Oprea-Călin Gabriela, et al.
Published: (2014-06-01)

Evaluation of clinical efficiency of Decap replacement therapy in patients with type 2 diabetes mellitus and concomitant nonalcoholic fatty liver disease in vitamin D deficiency
by: М.B. Аludwan, et al.
Published: (2020-11-01)